XML 58 R45.htm IDEA: XBRL DOCUMENT v3.22.4

ACQUISITIONS AND DIVESTITURES - Definite Lived Intangible Assets (Details) - USD ($) $ in Thousands	Apr. 05, 2022	Jun. 28, 2021	Mar. 30, 2021	Mar. 29, 2021	Dec. 31, 2020	Aug. 06, 2020	Jan. 03, 2020
Explora BioLabs
Business Acquisition [Line Items]
Definite-lived intangible assets acquired	$ 70,100
Weighted average amortization life of intangible assets acquired	12 years
Vigene Biosciences, Inc.
Business Acquisition [Line Items]
Definite-lived intangible assets acquired		$ 93,900
Weighted average amortization life of intangible assets acquired		11 years
Retrogenix Limited
Business Acquisition [Line Items]
Definite-lived intangible assets acquired			$ 22,126
Weighted average amortization life of intangible assets acquired			11 years
Cognate BioServices, Inc.
Business Acquisition [Line Items]
Definite-lived intangible assets acquired				$ 270,900
Weighted average amortization life of intangible assets acquired				13 years
Distributed Bio, Inc.
Business Acquisition [Line Items]
Definite-lived intangible assets acquired					$ 24,540
Weighted average amortization life of intangible assets acquired					7 years
Cellero, LLC
Business Acquisition [Line Items]
Definite-lived intangible assets acquired						$ 16,230
Weighted average amortization life of intangible assets acquired						12 years
HemaCare Corporation
Business Acquisition [Line Items]
Definite-lived intangible assets acquired							$ 183,540
Weighted average amortization life of intangible assets acquired							18 years
Client relationships | Explora BioLabs
Business Acquisition [Line Items]
Definite-lived intangible assets acquired	$ 64,000
Weighted average amortization life of intangible assets acquired	13 years
Client relationships | Vigene Biosciences, Inc.
Business Acquisition [Line Items]
Definite-lived intangible assets acquired		$ 87,500
Weighted average amortization life of intangible assets acquired		12 years
Client relationships | Retrogenix Limited
Business Acquisition [Line Items]
Definite-lived intangible assets acquired			$ 17,340
Weighted average amortization life of intangible assets acquired			13 years
Client relationships | Cognate BioServices, Inc.
Business Acquisition [Line Items]
Definite-lived intangible assets acquired				$ 257,200
Weighted average amortization life of intangible assets acquired				13 years
Client relationships | Distributed Bio, Inc.
Business Acquisition [Line Items]
Definite-lived intangible assets acquired					$ 16,080
Weighted average amortization life of intangible assets acquired					9 years
Client relationships | Cellero, LLC
Business Acquisition [Line Items]
Definite-lived intangible assets acquired						$ 14,740
Weighted average amortization life of intangible assets acquired						13 years
Client relationships | HemaCare Corporation
Business Acquisition [Line Items]
Definite-lived intangible assets acquired							$ 170,390
Weighted average amortization life of intangible assets acquired							19 years
Other intangible assets | Explora BioLabs
Business Acquisition [Line Items]
Definite-lived intangible assets acquired	$ 6,100
Weighted average amortization life of intangible assets acquired	4 years
Other intangible assets | Vigene Biosciences, Inc.
Business Acquisition [Line Items]
Definite-lived intangible assets acquired		$ 6,400
Weighted average amortization life of intangible assets acquired		2 years
Other intangible assets | Retrogenix Limited
Business Acquisition [Line Items]
Definite-lived intangible assets acquired			$ 4,786
Weighted average amortization life of intangible assets acquired			3 years
Other intangible assets | Cognate BioServices, Inc.
Business Acquisition [Line Items]
Definite-lived intangible assets acquired				$ 13,700
Weighted average amortization life of intangible assets acquired				2 years
Other intangible assets | Distributed Bio, Inc.
Business Acquisition [Line Items]
Definite-lived intangible assets acquired					$ 8,460
Weighted average amortization life of intangible assets acquired					4 years
Other intangible assets | Cellero, LLC
Business Acquisition [Line Items]
Definite-lived intangible assets acquired						$ 1,490
Weighted average amortization life of intangible assets acquired						3 years
Other intangible assets | HemaCare Corporation
Business Acquisition [Line Items]
Definite-lived intangible assets acquired							$ 5,820
Weighted average amortization life of intangible assets acquired							3 years
Trade name | Cellero, LLC
Business Acquisition [Line Items]
Definite-lived intangible assets acquired						$ 0
Trade name | HemaCare Corporation
Business Acquisition [Line Items]
Definite-lived intangible assets acquired							$ 7,330
Weighted average amortization life of intangible assets acquired							10 years

X

- Definition

Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

+ Details

Name:	us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

+ Details

Name:	us-gaap_FinitelivedIntangibleAssetsAcquired1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=crl_ExploraBioLabsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=crl_VigeneBiosciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=crl_RetrogenixLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=crl_CognateBioServicesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=crl_DistributedBioIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=crl_CelleroLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=crl_HemaCareCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: